Biogen is a global biotechnology company focused on advancing research and treatments in neuroscience, neurology, immunology, and rare diseases. The company is dedicated to transforming patient lives through innovative disease research and developing products that address complex medical conditions. Biogen operates across multiple therapeutic areas including organ transplantation and immune-mediated diseases, with a strong emphasis on translational science and early clinical development. The company leverages cutting-edge technologies, including digital solutions and biomarkers, to optimize clinical trials and bring products to market efficiently.
Industry
Biotechnology
Company Size
5001-10000 employees
Founded
1983
Beta · Sourced from candidate reports
Be the first to share your experience with Biogen.
Your reply helps other candidates know what to expect.
